跳至主要内容
临床试验/NCT05204017
NCT05204017招募中不适用

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

University of Alberta7 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
7
主要终点
ALS Functional Rating Scale-Revised (ALSFRS-R)

研究概览

简要总结

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.

详细描述

In this observational study, participants with ALS and related disorders will be followed longitudinally over the course of a year to examine disease progression. Participants with ALS or a related disorder will have up to 5 in-person visits at screening, 0, 4, 8 and 12 months. Healthy controls are included as comparisons and will have 3 in-person visits at screening, 0 and 8 months. At each visit after screening, patients and healthy controls will undergo an MRI, neurocognitive and speech testing, clinical evaluations specific to ALS (ALSFRS-R, FVC, neurological exam, which are not completed by controls), answer questionnaires about their health and have biospecimens, including blood, saliva and optionally cerebrospinal fluid, collected.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • [PATIENTS]
  • Inclusion Criteria:
  • Has ALS, classified as definite, probable, laboratory-supported probable, or possible ALS according to the revised El Escorial criteria or a related neurodegenerative disorder including ALS-FTD, PLS, PMA or asymptomatic individuals with a known ALS mutation (as previously confirmed during regular clinical care)
  • Be of the age of majority in their province of residence/treatment
  • Have the cognitive capacity to provide informed consent
  • Have proficiency in English or French in order to understand study instructions and respond to questionnaires

排除标准

  • [HEALTHY CONTROLS]
  • Inclusion Criteria:
  • Be between the ages of 40-80 unless age matched to a patient (+/-3 years) who is already enrolled
  • Be the age of majority in their province of residence/treatment
  • Have the cognitive capacity to provide informed consent
  • Have proficiency in English of French to understand study instructions and respond to questionnaires
  • Exclusion Criteria:
  • A history of a neurological disease, including Central Nervous System disease (e.g., stroke, head injury, epilepsy) or Peripheral Nervous System disease (neuropathy, myopathy)
  • A history of psychiatric disease (e.g. depression, bipolar disease) that is clinically diagnosed and/or with the current use of psychiatric medications (e.g. antidepressants) for an indication of a psychiatric disease.
  • Subjects ineligible for an MRI due to a pacemaker or other contraindication according to local MRI policies of the study centre.
  • Significant claustrophobia that would prohibit an MRI (subjects will be required to lie in an MRI scanner for approximately one hour).

结局指标

主要结局

ALS Functional Rating Scale-Revised (ALSFRS-R)

时间窗: Once every 4 months for a year

The ALSFRS-R will be used as a global measure of disease status. It measures activities of daily living and consists of 12 questions, each scored from 0-4, with higher scores representing better function. Changes in ALSFRS-R score over time will be measured.

Forced Vital Capacity (FVC)

时间窗: Once every 4 months for a year

FVC will be used as an index of respiratory function over time. FVC is the maximal volume of air exhaled with maximally forced effort from a maximal inspiration.

Magnetic Resonance Imaging (MRI)

时间窗: Once every 4 months for a year

Various advanced MRI techniques will be used to assess nervous system structure and function.

Edinburgh Cognitive and Behavioural Screen (ECAS)

时间窗: Once every 4 months for a year

Changes in cognitive function over time will be measured by the ECAS.

ALS Assessment Questionnaire (ALSAQ-5)

时间窗: Once every 4 months for a year

Changes in quality of life over time will be measured using the ALSAQ-5, a participant reported outcome measure.

World Health Organization Quality of Life Questionnaire (WHO-QOL-BREF)

时间窗: Once every 4 months for a year

Changes in quality of life over time will be measured using the WHO-QOL-BREF, a participant reported outcome measure.

Speech Testing

时间窗: Once every 4 months for a year

Changes in speech function over time will be measured using a web-browser based audio and video data collection tool.

Neurological dysfunction as detected during standard neurological examination

时间窗: Once every 4 months for a year

Changes in neurological function over time will be measured through a standard neurological examination.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Comprehensive Analysis Platform To Understand,... | 临床试验